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The movement of lymphocytes into’organized lymphoid 
tissues, the recruitment of leukocytes into inflammatory le- 
sions, and the formation of platelet plugs at sites of vascu- 
lar injury all begin with the attachment of circulating cells 
to modified regions of the vessel wall. Multiple indepen- 
dently regulated cell-cell and cell-matrix interactions 
contribute, and several families of adhesion molecules, in- 
cluding members of the integrin and immunoglobulin su- 
pergene families, have been characterized. This review 
focuses on the adhesive interaction of lymphocytes and 
vessel wall during recirculation in an effort to place two 
new families of adhesion receptors in a physiologic con- 
text. The first includes the murine lymphocyte “homing 
receptor” Mel-14 (Lasky et al., 1989; Siegelman et al., 
1989), the human endothelial leukocyte adhesion mole- 
cule ELAM-1 (Bevilacqua et al., 1989) and a potential 
adhesion structure of platelets and endothelial cells 
termed granule membrane protein or GMP-140 (Johnston 
et al., 1989). The second includes the Hermes/CD44 
group of broadly distributed membrane antigens impli- 
cated in lymphocyte-endothelial cell adhesion in multiple 
tissues (Goldstein et al., 1989; Stamenkovic et al., 1989; 
ldzerda et al., 1989). 
Lymphocyte Homing Depends on Tissue-Specific 
Adhesive Interactions with Endothelium 
Studies of migratory activity in situ indicate that lympho- 
cytes continuously recirculate from blood, through widely 
distributed organized lymphoid tissues, into the lymphat- 
its, and back to the blood-demonstrating, to a degree, 
regional specificities (reviewed in Yednock and Rosen, 
1989). In particular, peripheral lymph nodes and mucosal- 
associated lymphoid tissues constitute separate but over- 
lapping recirculatory pathways. A histologically distinctive 
postcapillary venule termed the high endothelial venule 
(HEV) serves as the portal of entry for circulating cells into 
organized lymphoid tissues along both pathways. The 
concept of “lymphocyte homing”-specifically, that lym- 
phocytes, unlike granulocytes and monocytes, are targeted 
for specific organs-grew out of these observations. AS 
documented below, the organ-selective attachment of cir- 
culating cells to the HEVs of target organs both initiates 
recirculation and governs specificity. 
Initial Characterization of Homing Receptors 
and Vascular Addressins 
The Stamper-Woodruff assay, a technique for quantitat- 
ing adhesive interactions between viable lymphocytes 
and HEVs in frozen sections of target organs, permits dis- 
section of homing activity at the molecular level. In rodent 
model systems, this assay detects organ-selective adhe- 
sive interactions and predicts migratory activity in vivo. 
Discrete adhesion molecules (termed homing receptors) 
mediate the binding of lymphoid cells to the HEVs of pe- 
ripheral lymph nodes (PNHEVs) and the intestinal Peyer’s 
patches (PPHEVs). Blockade with specific monoclonal 
antibodies (MAbs) prevents the migration of circulating 
cells into target organs in vivo, confirming the physiologic 
relevance of the adhesive interactions. 
In the rat, factors isolated from thoracic duct lymph, 
termed HEBFr, and HEBF,,, bind to HEVs and block 
lymphocyte attachment to PNHEVs or PPHEVs exclu- 
sively (reviewed in Woodruff et al., 1987). In contrast, 
MAbs raised to these factors selectively block attachment 
by interacting with lymphocyte antigens. MAb A.11 blocks 
attachment to PNHEVs and precipitates glycoproteins of 
135,60 and 40 kd, whereas MAb 1.82, an inhibitor of bind- 
ing to PPHEVs, precipitates a single 80 kd species. Thus 
discrete structures on normal rat lymphocytes mediate the 
interactions with PNHEVs and PPHEVs. 
In the murine system, MAb Mel-14 blocks the interac- 
tions, both in vitro and in vivo, of lymphoid cells with the 
HEVs of lymph nodes exclusively (reviewed in Berg et al., 
1989). Expression of the Mel-14 epitope correlates with 
binding and recirculatory efficiency in adult thymocytes 
(low), interleukin-2-dependent T cell clones (low), stimu- 
lated B cells isolated from germinal centers (low), unfrac- 
tionated nodal lymphocytes (high), and murine lympho- 
mas (low-very high). The Mel-14 epitope of lymphocytes 
resides on a highly glycosylated 85-95 kd glycoprotein 
with an unusually low isoelectric point (4.0-4.5). Finally, 
expression of the Mel-14 epitope on all leukocytes coupled 
with antibody-induced blockade of leukocyte accumula- 
tion in a cutaneous model of acute inflammation suggests 
that this “homing receptor” may contribute broadly to leu- 
kocyte-endothelial cell interactions. 
In contrast, MAb LPAM-1 effectively blocks binding of 
murine lymphoid cells to PPHEVs exclusively (Holzmann 
et al., 1989). The epitope resides on the high molecular 
weight chain of a heterodimer consisting of noncovalently 
associated 160 and 130 kd subunits. The 160 kd subunit 
cross-reacts with a monospecific rabbit anti-human VLA-4 
a chain reagent, linking the LPAM-1 receptor to the VLAl 
ECMR integrin family and raising the posssibility that its 
endogenous ligand resides in the extracellular matrix. 
Alternatively, the novel 8 chain identified in the LPAM-1 
antigen, termed &,, may distinguish a new subfamily 
specialized for intercellular adhesion, analogous to the 
CDlla-c/CD18 group. The precise relationship of the 
LPAM-1 receptor to other members of the VLAlECMR sub- 
family of integrins and its role in mediating selective 
migration in vivo remain to be determined. 
The prediction that tissue-selective adhesion structures 
associate with HEVs has recently been confirmed. TWO 
structurally distinct antigens, termed vascular addressins, 
are linked to homing in the nodal and mucosal recircula- 
tory pathways (reviewed in Berg et al., 1989). MAbs 
MECA-79 and MECA-367, specific for the nodal and 
mucosal addressins, respectively, block interactions with 
the appropriate target endothelium and show a reciprocal 
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pattern of expression in the adult mouse: the MECA-79 an- 
tigen predominates in PNHEVs and the MECA-367 anti- 
gen predominates in PPHEVs. In contrast, both are ex- 
pressed on the HEVs of mesenteric nodes. This pattern 
mirrors the binding characteristics of tissue-selective lym- 
phomas that interact with mesenteric HEVs at reduced 
levels whether their primary target is PNHEVs or PPHEVs. 
These molecules therefore are prime candidates for the 
endogenous ligands of the Mel-14 and LPAM-1 receptors. 
Finally, the expression of the addressins on endothelium 
outside the traditional nodal and mucosal recirculatory 
pathways suggests that they function as inducible adhe- 
sion molecules in a variety of tissues. 
Traditionally, the term “homing receptor” is applied to 
lymphocyte structures conferring tissue-selective migra- 
tory activity. However,  these molecules are not the exclu- 
sive determinants of migration. In the murine system, anti- 
LFA-1 MAbs partially block (~40%) the interactions of 
lymphocytes with both PNHEVs and PPHEVs (Hamann et 
al., 1988). MAb Mel-14, in contrast, inhibits activity in vitro 
and in vivo by >80%. Expression of the Mel-14 antigen on 
lymphomas bearing markedly elevated levels of LFA-1 sig- 
nificantly reduces the inhibitory effect of anti-LFA-1 MAbs 
on binding to PNHEVs. MAb Mel-14 alone blocks attach- 
ment (>90%), regardless of the relative densities of the 
Mel-14 and LFA-1 antigens. Thus LFA-1 augments organ- 
selective interactions mediated by homing receptors. In 
addition, the up-regulation of LFA-1 and its ligands (e.g., 
ICAM-1) during activation of human lymphocytes and en- 
dothelium, respectively, suggests that these molecules 
may enhance the migration of circulating activated lym- 
phocytes and foster extravasation into inflammatory le- 
sions (Dustin and Springer, 1988). Thus the concerted 
action of tissue-specific and multipurpose adhesion struc- 
tures regulates lymphocyte trafficking through organized 
lymphoid tissues. The validity of this paradigm in inflam- 
matory lesions remains to be established. However,  the 
development of HEV-like vessels at sites of chronic inflam- 
mation suggests mechanistic links to the recirculatory 
process. 
Characterization of Potential HEY Adhesion 
Molecules on Human Lymphocytes 
The Hermes/CD44 group of membrane antigens has 
been implicated in binding to HEVs in a variety of t issues 
(reviewed in Berg et al., 1989). Four principle lines of evi- 
dence support this hypothesis. First, FACS enrichment of 
the Hermes-l epitope on the CEM cell line correlates with 
increased affinity for PNHEVs. Second, purified Hermes-l 
antigen absorbs PNHEV blocking activity from rat anti- 
human whole lymphocyte antiserum. Third, MAb Hermes- 
3 blocks binding of lymphoid cells to the HEVs of mucosal 
lymphoid organs. Finally, mouse anti-human polyclonal 
Hermes antiserum blocks attachment of lymphoid cells to 
the HEVs of lymph nodes, mucosal lymphoid organs, and 
rheumatoid synovium. The absence of significant bio- 
chemical differences in the Hermes antigens isolated 
from cell lines binding exclusively to either lymph node or 
mucosal HEVs, coupled with the broad inhibitory specific- 
ity of the polyclonal antiserum, suggests that the Hermes 
antigens function as multipurpose adhesion receptors. Al- 
ternatively, Hermes antigens may coregulate and complex 
with organ-selective adhesion receptors in the cell mem- 
brane. Inhibition by Hermes-specif ic reagents might thus 
reflect steric hindrance of the principal attachment site. 
An immunologically and structurally related molecule 
isolated from a human fibrosarcoma line, termed CR/ 
ECMRIII, interacts with immobilized type I and type VI col- 
lagen (Carter and Wayner,  1988; Gallatin et al., 1989). Fur- 
thermore, both CRlECMRlll and murine Pgpl, the leading 
candidate for the murine homolog of the Hermes/CD44 
group, interact with the cytoskeleton. Thus members of 
this family may link adhesive interactions at the cell sur- 
face with the cytoskeleton. A more generalized role in cel- 
lular adhesion has been proposed in light of the broad ex- 
pression of Hermes/CD44 epitopes on hematopoietic, 
mesenchymal, and epithelial cell lines. 
A second potential adhesion molecule on human lym- 
phocytes reacts with MAb 3.A.7 (Woodruff et al., 1987). 
This MAb blocks the binding of human lymphocytes to 
PNHEVs and precipitates a single 80 kd protein from 
surface-labeled cells. The structural relatedness of 3.A.7 
to the murine Mel-14 antigen or the human Hermes/CD44 
antigens cannot be determined from currently available 
data. This question assumes greater importance in light 
of the sequence data showing that the Mel-14 and 
Hermes/CD44 antigens are not homologs. Thus MAb 
3.A.7 may join the growing legion of CD4Cspecif ic re- 
agents or constitute the only currently available monoclo- 
nal probe for the human homolog of the Mel-14 antigen. 
A Lectin-like Structure Mediates Lymphocyte 
Binding to the PNHEVs of Rodents and Man 
In the rat, mouse, and human, functionally similar calcium- 
dependent phosphomannosyl binding sites on intact cells 
have been linked to recognition of PNHEVs (Stoolman et 
al., 1987; reviewed in Yednock and Rosen, 1989). In all 
three species, mannose-6-phosphate (M6P), the structur- 
ally related monosaccharide fructose-l-phosphate, the fu- 
case sulfate-rich heteropolysaccharide fucoidin, and the 
MGP-rich phosphomannan PPME efficiently block attach- 
ment to PNHEVs. The monosaccharides inhibit maximally 
(>80%) at 5-10 mM, while the polysaccharides show 
equal inhibition at 0.1-10 nM (depending on the species). 
A fluorescent probe for phosphomannan receptors, con- 
structed by derivatizing fluorescent microspheres with 
PPME (PPME-beads), binds to lymphoid cells in direct 
proportion to the cells’ affinity for PNHEVs. The attach- 
ment of lymphocytes to both PNHEVs and PPME-beads 
is calcium dependent, trypsin sensitive, and blocked by 
the same group of carbohydrates. Thus PPME-beads de- 
tect a lectin-like receptor on lymphocytes mediating at- 
tachment to PNHEVs. 
In the murine system this site is either contained in or 
intimately associated with the Mel-14 antigen. Lectin activ- 
ity, cell-surface Mel-14 antigen, and affinity for PNHEVs 
are expressed at similar levels in thymocytes, recirculat- 
ing lymphocytes, and a variety of lymphomas. Moreover, 
enriching the S49 lymphoma line for surface lectin activity 
increases expression of the Mel-14 epitope in parallel 
(correlation coefficient near unity). Finally, MAb Mel-14 in- 
hibits the attachment of PPME-beads to lymphocytes in a 
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Compendium of Adhesion Structures 
Function Molecule Size (kd) Distribution Ligand(s) 
Lymphocyte Adhesion 





PPHEVs and MNHEVs 1.82 
LPAM-1 (VLA4)c 
MECA-367 antigen 
HEVs of multiple tissues Hermes antigens 
(CD443 Pap1 > 
CRIECMRIII, 
Hutchl) 
92 murine PNHEVs and MNHEVs 
80 rat lymphs 
1601130 murine lymphs and malignant lines 
58-66 murine PPHEVs and MNHEVs 
80-95, 160, 
180-200 
LFA-I (CD1 la/18)c 180/95 
ICAM-1” 90 
Leukocyte Adhesion ELAM-la 
LFA-I (CD1 1 a/18)c 
CR3 (CD1 1 b/18, Macl, 
Mel, OKMI, Leu15)c 
p150,95 (CDlld18)C 
Platelet Adhesion - GMP-140a 140 
GP I complex 150 
GP Ilb, lilac 1301231105 










murine lymphs, PMNs. and 
malignant lymphoid lines 
lymphs and malignant lymphoid 
lines in rodents and humans 
hematopoietic, epithelial, mesen- 
chymal cells and related lines in 
humans, nonhuman primates, 
and mouse 
all murine and human leukocytes, 
related lines 
widely distributed, frequently up 
regulated with activation (endo- 
thelium, keratinocytes) 
endothelium of immune/inflammatory 
lesions; cytokine-treated HUVE 
all murine and human leukocytes, 
related lines 
PMNs, monocytes, macrophages, 
LGLs 
PMNs, monocytes, macrophages, 
CTL lines 
alpha granules of platelets and 
Weibel-Pallade bodies of endo- 
thelium; rapidly mobilized to 
plasma membrane on stimulation 
platelet plasma membrane 
platelet plasma membrane 
unknown 
unknown 
?sialyloligosaccharide on HEV 





?ECM, ?MECA-367 antigen 
?LPAM-1 
?ECM 
ICAM-1, other HUVE ligand(s) 
LFA-1 
unknown 
ICAM-1, other HUVE ligand(s) 
CBbi, ?endothelial ligands 
CSbi, ?endothelial ligands 
unknown 
vWF 
RGD sequence in fibrinogen, 
fibronectin, and vWF 
a New LEC-CAM family (for lectin, EGF, and complement homology domains; see text). 
b Characterized on intact cells only; probably equivalent to the Mel-14 antigen (mouse) and its structural homologs in rat and human. 
c lntegrin family. 
d lmmunoglobulin supergene family. 
PNHEVs, MNHEVs, and PPHEVs = high endothelial venules of peripheral lymph nodes, mesenteric lymph nodes, and Peyer’s patches; M6P 
= mannose-6-phosphate; FIP = fructose-l-phosphate; HUVE = human umbilical vein endothelium; LGLs = large granular lymphocytes; CTLs 
= cytolytic T cells; vWF = von Willebrand factor. 
dose-dependent fashion whereas MAbs directed at a vari- 
ety of other lymphocyte antigens have no effect. In all spe- 
cies and cell lines tested to date, calcium-dependent lec- 
tin activity at the cell surface correlates directly with 
affinity for PNHEVs. These functional studies predict that 
structurally conserved carbohydrate binding domains 
mediate attachment to PNHEVs in both rodents and man. 
As detailed below, the sequence of the murine Mel-14 anti- 
gen provides support for this hypothesis. 
The endogenous ligand for the lectin has not been iden- 
tified; however, terminal sialic acid residues appear criti- 
cal since desialylation of murine HEVs blocks attachment 
to lymph nodes but not to Peyer’s patches (reviewed in 
Yednock and Rosen, 1989). At present there is no direct 
evidence that M6P residues contribute to the binding site 
on the HEVs. Thus the anionic carbohydrate inhibitors 
characterized to date may mimic the charge distribution 
of the endogenous ligand. However,  the potency and 
specificity of these inhibitors suggest that they resemble 
the endogenous structure in critical respects. One attrac- 
tive hypothesis, prompted by the inhibitory activity of neur- 
aminidase and the known structural diversity of sialic 
acids, is that an unusual form of sialic acid constitutes the 
endogenous receptor. 
The Mel-14 Antigen Contains a Carbohydrate 
Binding Domain and Is Structurally Unrelated 
to the Hermes/CD44 Antigen Group 
The primary sequence of Mel-14 reveals a novel structure 
composed of an N-terminal lectin-like domain contiguous 
with a single epidermal growth factor (EGF)-like repeat 
and two identical repeats homologous to a variety of com- 
plement binding proteins (Lasky et al., 1989; Siegelman 
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et al., 1989). A hydrophobic transmembrane domain and 
a short cytoplasmic tail with one potential phosphorylation 
site round out the structure. The presence of a prominent 
amino-terminal sequence homologous to a variety of 
C-type animal lectins supports the hypothesis that the 
carbohydrate recognition domain mediates binding to 
PNHEVs. In particular, the strict calcium dependence of 
carbohydrate recognition by sequences displaying the 
“Drickamer” motif (Drickamer, 1988), as in the Mel-14 anti- 
gen, mirrors precisely the cation requirements of lympho- 
cyte interactions with both PNHEVs and PPME-beads. In 
contrast, two homologous complement binding molecules, 
C2 and protein B, associate with their ligands (C4b and 
C3b, respectively) in a magnesium-dependent fashion 
(Reid et al., 1986). Magnesium cannot substitute for cal- 
cium in functional studies of the homing receptor on intact 
cells. Thus the amino-terminal sequence must be consid- 
ered the leading candidate for the HEV and PPME recog- 
nition domains. However,  confirmation awaits structure- 
function studies of each extracellular domain and charac- 
terization of the endogenous ligand. 
The demonstration of a similar structure for ELAM-1 
(Bevilacqua et al., 1989) and GMP-140 (Johnston et al., 
1989) suggests that carbohydrate-dependent adhesion 
may contribute to a broad range of recognition events in- 
volving hematopoietic cells. ELAM-1 mediates the attach- 
ment of neutrophils to cytokine-activated endothelium in 
vitro. It appears in situ on endothelium in immune/inflam- 
matory lesions, consistent with a role in the recruitment of 
circulating leukocytes. The function of GMP-140, a major 
constituent of cytoplasmic granules in platelets and en- 
dothelium, is not established; however, its structural ties 
to documented adhesion molecules enhances the likeli- 
hood that it fulfills a similar function. The ligation of lectin, 
EGF, and complement binding domains in this group of 
documented and potential adhesion molecules suggests 
the acronym LEC-CAM (for Lectin, EGF, Complement- 
Cellular Adhesion Molecule) for the family as a whole. 
Independent sequencing of cDNAs encoding the 
Hermes/CD44 antigen in several different lymphoid lines 
reveals a novel t ransmembrane molecule structurally un- 
related to the Mel-14 antigen (Goldstein et al., 1989; 
Stamenkovic et al., 1989; ldzerda et al., 1989). A poten- 
tially significant N-terminal homology (~30%) with carti- 
lage link proteins may provide a structural basis for inter- 
actions with proteoglycans and collagen, although an 
actual contribution of extracellular matrix components to 
Hermes-sensit ive adhesive interactions has not been es- 
tablished. The presence of Hermes-encoding mRNAs of 
the same size in a variety of hematopoietic cells express- 
ing the 80-90 kd form suggests that the antigens share a 
common core protein sequence. However,  the slightly 
larger mRNAs in epithelial cell lines expressing a 160 kd 
form may reflect the presence of sequence heterogeneity 
within the extended CD44 antigen family (Stamenkovic et 
al., 1989). The antigenic polymorphism reported for this 
group may thus result from sequence heterogeneity or 
cell-specific posttranslational modifications of a common 
core peptide. Overall, the structural data are consistent 
with Hermes functioning as a non-tissue-selective HEV 
adhesion molecule in the Stamper-Woodruff assay. Con- 
firmation of this hypothesis and delineation of the anti- 
gen’s function on nonlymphoid cells remain challenging 
tasks for the future. 
Summary 
Two newly characterized structural families of adhesion 
molecules, in concert with known members of the integrin 
and immunoglobulin supergene families, mediate the in- 
teraction of circulating lymphoid cells with the vessel wall. 
The Hermes/CD44 antigen family participates in attach- 
ment to multiple vascular beds and consists of a common 
polypeptide core showing amino-terminal homology to 
cartilage link proteins. In contrast, the node-specific hom- 
ing receptor Mel-14 consists of substructures homologous 
to calcium-dependent lectins, EGF, and complement bind- 
ing proteins. The sequence of Mel-14 provides structural 
support for the hypothesis that lectin-carbohydrate inter- 
actions mediate physiologically significant adhesion events 
in the course of lymphocyte recirculation. The discovery 
of a similar structure in ELAM-1 and GMP-140 extends the 
reach of this family to other leukocyte and platelet interac- 
tions with the vessel wall. 
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